Skip to main content
Log in

Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

The aim of this study was to determine the effect of chromium (Cr)-enriched yeast on blood glucose and insulin variables, blood lipids, and blood markers of oxidative stress in persons with type 2 diabetes mellitus (median duration: 3.0 yr). Thirty-six subjects (9 men, 27 women; mean age: 61.3 yr; mean body mass index: 34.33 kg/m2) were supplemented with 400 μg Cr/d as Cr-enriched yeast (n=19) or placebo (n=17) for 12 wk in a randomized, double-blind study. The most interesting results were obtained by comparison of the change in the placebo group to the change in the Cr group. The Cr group showed a significantly greater increase in serum Cr compared to the placebo group (p<0.05). Supplementation with Cr-enriched yeast was associated with a significant decrease in fasting serum glucose compared to placebo (p<0.01). Blood markers of oxidative stress glutathione peroxidase activity and levels of reduced glutathione were essentially unchanged in the Cr group after 12 wk, but decreased significantly in the placebo group (p<0.05, p<0.01, respectively), Serum HbA1c and glycated protein (fructosamine) were essentially unchanged in the Cr group, whereas HbA1c tended to increase in the placebo group (from 6.94% to 7.11%). Fasting serum insulin decreased in both groups, with a greater tendency in the Cr group (−16.5% vs −9.5%). These data suggest that supplementation of well-controlled type 2 diabetics with Cr-enriched yeast is safe and can result in improvements in blood glucose variables and oxidative stress.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. K. Schwarz and W. Mertz, Chromium (III) and the glucose tolerance factor, Arch. Biochem. Biophys. 85, 292–295 (1959).

    Article  PubMed  CAS  Google Scholar 

  2. I. W. Davidson and W. L. Blackwell, Changes in carbohydrate metabolism of squirrel monkeys with Chromium dietary supplementation, Proc. Soc. Exp. Biol. Med. 127, 66–70 (1968).

    PubMed  CAS  Google Scholar 

  3. K. N. Jeejeebhoy, R. C. Chu, E. B. Marliss, G. R. Greenberg, and A. Bruce-Robertson, Chromium deficiency, glucose intolerance, and neuropathy reversed by Chromium supplementation, in a patient receiving long-term total parenteral nutrition, Am. J. Clin. Nutr. 30, 531–538 (1977).

    PubMed  CAS  Google Scholar 

  4. R. A. Anderson, N. Cheng, N. A. Bryden, et al., Elevated intakes of supplemental Chromium improve glucose and insulin variables in individuals with type 2 diabetes, Diabetes 46, 1786–1791 (1997).

    PubMed  CAS  Google Scholar 

  5. C. M. Davis and J. B. Vincent, Chromium oligopeptide activates insulin receptor tyrosine kinase activity, Biochemistry 36, 4382–4385 (1997).

    Article  PubMed  CAS  Google Scholar 

  6. J. B. Vincent Elucidating a biological role for Chromium at a molecular level, Acc. Chem. Res. 33, 503–510 (2000).

    Article  PubMed  CAS  Google Scholar 

  7. J. B. Vincent, Recent advances in the nutritional biochemistry of trivalent Chromium, Proc. Nutr. Soc. 63, 41–47 (2004).

    Article  PubMed  CAS  Google Scholar 

  8. J. B. Vincent, Recent developments in the biochemistry of Chromium(III), Biol. Trace Element Res. 99, 1–16 (2004).

    Article  CAS  Google Scholar 

  9. M. H. Mendler, B. Turlin, R. Moirand, et al., Insulin resistance-associated hepatic iron overload, Gastroenterology, 117, 1155–1163 (1999).

    Article  PubMed  CAS  Google Scholar 

  10. W. Ding, Z. Chai, P. Duan, W. Feng, and Q. Qian, Serum and urine Cr concentrations in elderly diabetics, Biol. Trace Element Res. 63, 231–237 (1998).

    CAS  Google Scholar 

  11. B. W. Morris, S. MacNeil, C. A. Hardisty, S. Heller, C. Burgin, and T. A. Gray, Chromium homeostasis in patients with type II (NIDDM) diabetes, J. Trace Elements Med. Biol. 13, 57–61 (1999).

    CAS  Google Scholar 

  12. G. J. Ryan, N. S. Wanko, A. R. Redman, and C. B. Cook, Chromium as adjunctive treatment for type 2 diabetes, Ann. Pharmacother. 37, 876–885 (2003).

    Article  PubMed  CAS  Google Scholar 

  13. S. M. Bahijiri, S. A. Mira, A. M. Mufti, and M. A. Ajabnoor, The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes, Saudi Med. J. 21, 831–837 (2000).

    PubMed  CAS  Google Scholar 

  14. M. I. Uusitupa, L. Mykkanen, O. Siitonen, et al., Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels, Br. J. Nutr. 68, 209–216 (1992).

    Article  PubMed  CAS  Google Scholar 

  15. N. A. Lee and C. A. Reasner, Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM, Diabetes Care 17, 1449–1452 (1994).

    PubMed  CAS  Google Scholar 

  16. R. A. Anderson, A. M. Roussel, N. Zouari, S. Mahjoub, J. M. Matheau, and A. Kerkeni, Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus, J. Am. Coll. Nutr. 20, 212–218 (2001).

    PubMed  CAS  Google Scholar 

  17. E. G. Offenbacher and F. X. Pi-Sunyer, Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects, Diabetes 29, 919–925 (1980).

    PubMed  CAS  Google Scholar 

  18. R. T. Mossop, Effects of chromium III on fasting blood glucose, cholesterol and cholesterol HDL levels in diabetics, Central Afr. J. Med. 29, 80–82 (1983).

    CAS  Google Scholar 

  19. C. D. Hunt and B. J. Stoecker, Deliberations and evaluations of the approaches, endpoints and paradigms for boron, chromium and fluoride dietary recommendations, J. Nutr. 126, 2441S-2451S (1996).

    PubMed  CAS  Google Scholar 

  20. M. D. Althuis, N. E. Jordan, E. A. Ludington, and J. T. Wittes, Glucose and insulin responses to dietary chromium supplements: a meta-analysis, Am. J. Clin. Nutr. 76, 148–155 (2002).

    PubMed  CAS  Google Scholar 

  21. J. K. Speetjens, R. A. Collins, J. B. Vincent, and S. A. Woski, The nutritional supplement chromium (III) tris(picolinate) cleaves DNA, Chem. Res. Toxicol 12, 483–487 (1999).

    Article  PubMed  CAS  Google Scholar 

  22. N. F. Wiernsperger, Oxidative stress: the special case of diabetes, Biofactors 19, 11–18 (2003).

    PubMed  CAS  Google Scholar 

  23. D. Giugliano, A. Ceriello, and G. Paolisso, Oxidative stress and diabetic vascular complications, Diabetes Care 19, 257–267 (1996).

    PubMed  CAS  Google Scholar 

  24. A. M. Jentzsch, H. Bachmann, P. Furst, and H. K. Biesalski, Improved analysis of malondialdehyde in human body fluids, Free Radical Biol. Med. 20, 251–256 (1996).

    Article  CAS  Google Scholar 

  25. P. Chappuis, J. Poupon, J. F. Deschamps, P. J. Guillausseau, and F. Rousselet, Physiological chromium determination in serum by Zeeman graphite furnace atomic absorption spectrometry. A serious challenge, Biol. Trace Element Res. 32, 85–91 (1992).

    CAS  Google Scholar 

  26. B. D. Milne, Trace elements, in Tietz Fundamentals of Clinical Chemistry C. Burtis and E. Ashwood, eds., W. B. Saunders, Philadelphia, pp. 568–583 (2001).

    Google Scholar 

  27. N. Cheng, X. Zhu, H. Shi, et al., Follow-up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium, J. Trace Elements Exp. Med. 12, 55–60 (1999).

    Article  Google Scholar 

  28. S. M. A. Bahijri and A. M. B. Mufti, Beneficial effects of chromium in people with type 2 diabetes, and urinary chromium response to glucose load as a possible indicator of status, Biol. Trace Element Res. 85, 97–109 (2002).

    Article  CAS  Google Scholar 

  29. M. Rukgauer and A. Zeyfang, Chromium determinations in blood cells: clinical relevance demonstrated in patients with diabetes mellitus type 2, Biol. Trace Element Res. 86, 193–202 (2002).

    Article  Google Scholar 

  30. A. S. Kozlovsky, P. B. Moser, S. Reiser, and R. A. Anderson, Effects of diets high in simple sugars on urinary chromium losses, Metabolism 35, 515–518 (1986).

    Article  PubMed  CAS  Google Scholar 

  31. N. Cheng, X. Zhu, H. Shi, W. Wu, J. Chi, and J. Cheng, R. Anderson, Follow-up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium, Biol. Trace Elements Exp. Med. 12, 55–60 (1999).

    Article  Google Scholar 

  32. R. Riales and M. J. Albrink, Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men, Am. J. Clin. Nutr. 34, 2670–2678 (1981).

    PubMed  CAS  Google Scholar 

  33. V. L. Thomas and S. S. Gropper, Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors, Biol. Trace Element Res. 55, 297–305 (1996).

    CAS  Google Scholar 

  34. L. G. Trow, J. Lewis, R. H. Greenwood, et al., Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes, Int. J. Vitam. Nutr. Res. 70, 14–18 (2000).

    Article  PubMed  CAS  Google Scholar 

  35. H. Cheng, M. Lai, W. Hou, and C. Huang, Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects, J. Agric. Food Chem. 52, 1385–1389 (2004).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Racek, J., Trefil, L., Rajdl, D. et al. Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus. Biol Trace Elem Res 109, 215–230 (2006). https://doi.org/10.1385/BTER:109:3:215

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/BTER:109:3:215

Index Entries

Navigation